Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy.

Marton Graf1, Rita Jakus, Sandor Kantor

  • 1Laboratory of Neurochemistry and Experimental Medicine, National Institute of Psychiatry and Neurology, Huvosvolgyi ut 116, H-1021, Budapest, Hungary.

Neuroscience Letters
|March 31, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residual muscle activity associated with phantom limb movements after transhumeral amputation without surgical reinnervation: a preliminary ultrasound study.

Journal of neuroengineering and rehabilitation·2026
Same author

Variability in the effects of ketamine enantiomers across animal models of depression and implications for human studies.

British journal of pharmacology·2026
Same author

Differential effects of ketamine enantiomers on EEG parameters including the gamma-delta shift phenomenon.

British journal of pharmacology·2026
Same author

Correction to "Discovery of an In Vitro and In Vivo Potent Nicotinic α7 Positive Allosteric Modulator Clinical Candidate Molecule (RGH-857)".

Journal of medicinal chemistry·2026
Same author

Discovery of an In Vitro and In Vivo Potent Nicotinic α7 Positive Allosteric Modulator Clinical Candidate Molecule (RGH-857).

Journal of medicinal chemistry·2025
Same author

Three shades of gloom: investigating the genetic background of current depressive symptoms associated with different severity of current stress exposure in a general population.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025

Blocking serotonin 5-HT1A and 5-HT7 receptors reduces absence epilepsy activity in rats. Antagonists WAY-100635 and SB-258719 decreased spike-wave discharges, indicating these receptors regulate seizure activity.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Recent studies suggest 5-HT1A receptor activation exacerbates epileptic activity in the WAG/Rij rat model of absence epilepsy.
  • Emerging data also point to the involvement of 5-HT7 receptors in this epilepsy model.

Purpose of the Study:

  • To investigate the role of 5-HT1A and 5-HT7 receptors in regulating spontaneous epileptic activity.
  • To evaluate the effects of selective antagonists for these receptors on absence epilepsy in rats.

Main Methods:

  • Utilized the WAG/Rij rat model of absence epilepsy.
  • Administered selective 5-HT1A receptor antagonist WAY-100635.
  • Administered selective 5-HT7 receptor antagonist SB-258719.
  • Compared effects to vehicle treatment and analyzed spontaneous epileptic activity.

Related Experiment Videos

Main Results:

  • Both WAY-100635 and SB-258719 significantly reduced epileptic activity compared to vehicle.
  • Significant decreases were observed in the number of paroxysms.
  • Cumulative and average durations of spike-wave discharges (SWDs) were also significantly reduced.
  • The time courses of the effects differed between the two antagonists.

Conclusions:

  • Activation of both 5-HT1A and 5-HT7 receptors plays a crucial role in regulating SWD activity in this absence epilepsy model.
  • Selective antagonism of these receptors demonstrates therapeutic potential for reducing epileptic activity.
  • Further research into the distinct temporal roles of these serotonin receptors is warranted.